Current knowledge of Epigenetic Events in Multiple Myeloma | Chapter 7 | New Frontiers in Medicine and Medical Research Vol. 5
Multiple myeloma (MM) is a physiologically heterogeneous
illness characterised by a wide range of chromosomal, genetic, and epigenetic
alterations. Without affecting the DNA sequence, epigenetic changes can
influence gene function. DNA methylation and post-translational alteration of
histone proteins (histone methylation, acetylation, and deacetylation) are two
biochemical modifications that have a role in the pathogenesis of MM.
Epigenetic DNA methyltransferases (DNMTs), ten-eleven translocation enzymes (TET),
histone acetyltransferases (HATs), and histone deacetylases are examples of key
specialised enzymatic entities that mediate changes (HDACs). Micro-RNA
molecules have a role in epigenetic processes as part of a complicated
machinery. Not only does epigenetics play a role in myeloma genesis, but it
also has an impact on medication resistance and prognosis in individuals with
MM.
Author(s) Details
Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic
Luzna Petra
Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic
Weiser-Drozdkova Denisa
Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic
Smesny Trtkova Katerina
Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic
View Book :- https://stm.bookpi.org/NFMMR-V5/article/view/3016
Comments
Post a Comment